BACKGROUND: To date, few studies have assessed the influence of infections present on admission (POA) compared with hospital-acquired infections (HAIs) on neurologic deterioration (ND) and other outcome measures in acute ischemic stroke (AIS). METHODS: Patients admitted with AIS to our stroke center (July 2010 to December 2010) were retrospectively assessed. The following infections were assessed: urinary tract infection, pneumonia, and bacteremia. Additional chart review was performed to determine whether the infection was POA or HAI. We assessed the relationship between infections in ischemic stroke patients and several outcome measures including ND and poor functional outcome. A mediation analysis was performed to assess the indirect effects of HAI, ND, and poor functional outcome. RESULTS: Of the 334 patients included in this study, 77 had any type of infection (23 POA). After adjusting for age, National Institutes of Health Stroke Scale at baseline, glucose on admission, and intravenous tissue plasminogen activator, HAI remained a significant predictor of ND (odds ratio [OR]=8.8, 95% confidence interval [CI]: 4.2-18.7, P<.0001) and poor functional outcome (OR=41.7, 95% CI: 5.2-337.9, P=.005), whereas infections POA were no longer associated with ND or poor functional outcome. In an adjusted analysis, we found that 57% of the effect from HAI infections on poor functional outcome is because of mediation through ND (P<.0001). CONCLUSIONS: Our data suggests that HAI in AIS patients increases the odds of experiencing ND and subsequently increases the odds of being discharged with significant disability. This mediated effect suggests a preventable cause of ND that can thereby decrease the odds of poor functional outcomes after an AIS.
BACKGROUND: To date, few studies have assessed the influence of infections present on admission (POA) compared with hospital-acquired infections (HAIs) on neurologic deterioration (ND) and other outcome measures in acute ischemic stroke (AIS). METHODS:Patients admitted with AIS to our stroke center (July 2010 to December 2010) were retrospectively assessed. The following infections were assessed: urinary tract infection, pneumonia, and bacteremia. Additional chart review was performed to determine whether the infection was POA or HAI. We assessed the relationship between infections in ischemic strokepatients and several outcome measures including ND and poor functional outcome. A mediation analysis was performed to assess the indirect effects of HAI, ND, and poor functional outcome. RESULTS: Of the 334 patients included in this study, 77 had any type of infection (23 POA). After adjusting for age, National Institutes of Health Stroke Scale at baseline, glucose on admission, and intravenous tissue plasminogen activator, HAI remained a significant predictor of ND (odds ratio [OR]=8.8, 95% confidence interval [CI]: 4.2-18.7, P<.0001) and poor functional outcome (OR=41.7, 95% CI: 5.2-337.9, P=.005), whereas infections POA were no longer associated with ND or poor functional outcome. In an adjusted analysis, we found that 57% of the effect from HAI infections on poor functional outcome is because of mediation through ND (P<.0001). CONCLUSIONS: Our data suggests that HAI in AIS patients increases the odds of experiencing ND and subsequently increases the odds of being discharged with significant disability. This mediated effect suggests a preventable cause of ND that can thereby decrease the odds of poor functional outcomes after an AIS.
Authors: M Nilupul Perera; Henry K Ma; Shuji Arakawa; David W Howells; Romesh Markus; Christopher C Rowe; Geoffrey A Donnan Journal: J Clin Neurosci Date: 2006-01 Impact factor: 1.961
Authors: Andreas Hug; Alexander Dalpke; Nina Wieczorek; Thomas Giese; Alexander Lorenz; Gerd Auffarth; Arthur Liesz; Roland Veltkamp Journal: Stroke Date: 2009-08-06 Impact factor: 7.914
Authors: Andrea Rocco; Geraldine Fam; Marek Sykora; Jennifer Diedler; Simon Nagel; Peter Ringleb Journal: Int J Stroke Date: 2012-05-28 Impact factor: 5.266
Authors: Erica M Jones; Karen C Albright; Marco Fossati-Bellani; James E Siegler; Sheryl Martin-Schild Journal: Stroke Date: 2011-09-08 Impact factor: 7.914
Authors: R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo Journal: Public Health Rep Date: 2007 Mar-Apr Impact factor: 2.792
Authors: Neale R Chumbler; Linda S Williams; Carolyn K Wells; Albert C Lo; Steven Nadeau; Aldo J Peixoto; Mark Gorman; John L Boice; John Concato; Dawn M Bravata Journal: Neuroepidemiology Date: 2010-03-03 Impact factor: 3.282
Authors: Frederique H Vermeij; Wilma J M Scholte op Reimer; Peter de Man; Robert J van Oostenbrugge; Cees L Franke; Gosse de Jong; Paul L M de Kort; Diederik W J Dippel Journal: Cerebrovasc Dis Date: 2009-03-28 Impact factor: 2.762
Authors: Tiffany L Mathias; Karen C Albright; Amelia K Boehme; Dominique Monlezun; Alexander J George; Erica Jones; T Mark Beasley; Sheryl Martin-Schild Journal: J Cardiovasc Dis Date: 2014-01
Authors: Adam J Friedant; Brittany M Gouse; Amelia K Boehme; James E Siegler; Karen C Albright; Dominique J Monlezun; Alexander J George; Timothy Mark Beasley; Sheryl Martin-Schild Journal: J Stroke Cerebrovasc Dis Date: 2015-01-16 Impact factor: 2.136
Authors: James F Colbert; Richard J Traystman; Sharon N Poisson; Paco S Herson; Adit A Ginde Journal: J Stroke Cerebrovasc Dis Date: 2016-06-28 Impact factor: 2.136
Authors: Layne Dylla; Paco S Herson; Sharon N Poisson; John D Rice; Adit A Ginde Journal: J Stroke Cerebrovasc Dis Date: 2021-01-19 Impact factor: 2.136